Acute keratoconjunctivitis associated with tisotumab vedotin-tftv for metastatic cervical cancer
Purpose: Tisotumab vedotin-tftv, an antibody-drug conjugate, was recently FDA-approved for metastatic or treatment-resistant cervical cancer. A high rate of ocular comorbidities was seen in pivotal clinical trials. We present a case of a 46-year-old woman who experienced prolonged ocular surface adv...
שמור ב:
| Principais autores: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Elsevier
2024-03-01
|
| סדרה: | American Journal of Ophthalmology Case Reports |
| נושאים: | |
| גישה מקוונת: | http://www.sciencedirect.com/science/article/pii/S2451993623001871 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|